The Beauty of Taiwan

         Relapsing forms of Multiple Sclerosis（RMS）
         Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
         Briumvi vs Ocrevus: A Detailed Examination (2024)
         FDA Approves Ocrevus Zunovo™ as the First and Only Twice-A-Year 10-Minute Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis
         Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy
         Q3 2024 TG Therapeutics Inc Earnings Call
         TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion
         Multiple Sclerosis Therapeutic Market Size to Hit USD 46.44 Bn by 2033

         Small-cap stocks in the six months after previous U.S. presidential elections
         Small-cap stocks have been big gainers in the six months after previous U.S. presidential elections — but 2024-25 offers no guarantees.

         Online Stock Trading Platforms - Interactive Brokers
         A Deep Dive into Interactive Brokers (IBKR)
         Interactive Brokers (IBKR) Deep Dive

         Online Stock Trading Platforms - Robinhood
         Robinhood Stock: Should You Invest in the Company Today?
         Robinhood Q3 Surge: Global Expansion and New Trading Tools
         Robinhood Markets (HOOD) Q3 2024 Earnings Call Transcript
         Decoding Robinhood Markets Inc (HOOD): A Strategic SWOT Insight
         Robinhood Markets, Inc. Monthly Metrics

         Focusing on agility, innovation, and customers to help navigate complexities and meet new demands
         2025 global insurance outlook: Evolving industry operating models to build the future of insurance

         Reddit Statistics
         Reddit S-1 breakdown: On community, profitability, AI, and meme stocks
         Reddit Statistics 2024: Users, Revenue & More
         Reddit Announces Third Quarter 2024 Results
         Decoding Reddit Inc (RDDT): A Strategic SWOT Insight

         The Agentic Reasoning Era Begins
         Generative AI’s Act o1

         Generative AI would become a profound platform shift in technology
         Generative AI’s Act Two

         護腕的使用你用對了嗎?         護腕的使用你用對了嗎?

         PPL訓練課表(兩年進度)

         去年底臀肌不適，硬舉和深蹲的最大力量下降，休息了好幾個禮拜。今年七月開始減脂，目前體重流失約1.5公斤，維持在69~70公斤之間。預計三、四個月後將再度進行增肌。
         參考推拉腿(PPL)訓練課表，並且增減修改PPL訓練課表(一年進度)。每個訓練日的第一個訓練是主訓練，為大重量的槓鈴運動，即硬舉、臥推、深蹲，而剩下的訓練是副訓練，為次數較多、重量較輕、偏向健美式的訓練。週期採訓練三日休息一天，依序是 拉推腿休 - 拉推腿休 ... 周而復始，兩年的力量進度紀錄如下。
拉(PULL)
         硬舉：135kg 1X5
         引體向上：3X8-12
         滑輪下拉：48kg 3X8-12
         坐姿划船：48kg 3X8-12
         纜繩面拉：14kg 3X15-20
         反向飛鳥：45kg 3X15-20
         錘式彎舉：10kg 4X8-12
推(PUSH)
         臥推：70kg 5X5 或是 啞鈴臥推：30kg 5X5
         啞鈴上斜臥推：22kg 3X8-12 或是 史密斯上斜臥推：30kg 3X8-12
         雙槓撐體：3X8-12 或是 窄握臥推：40kg 3X8-12 或是 史密斯肩推：25kg 3X8-12 或是 啞鈴肩推：16kg 3X8-12
         啞鈴側平舉：6kg 3X15-20 或是 纜繩側平舉：3X15-20 或是 側肩上舉訓練機：27kg 3X15-20
         飛鳥夾胸：79kg 3X8-12
         三頭肌過頭伸展：13kg 3X8-12 或是 三頭肌纜繩下壓：11kg 3X8-12
         肩外旋：4X8-12
腿(LEGS)
         深蹲：100kg 3X5
         保加利亞分腿蹲：14kg 3X8-12
         槓鈴臀推：98kg 3X8-12
         羅馬尼亞硬舉：78kg 3X8-12
         大腿推蹬訓練機：220kg 3X8-12
         坐姿腿部彎曲機：29kg 3X8-12 或是 臥姿腿部彎曲機：27kg 3X8-12
         大腿內收機：36kg 3X8-12
         大腿外展機：50kg 3X8-12